Truehand Inc’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$102K Hold
1,161
0.06% 103
2021
Q3
$95K Hold
1,161
0.06% 104
2021
Q2
$106K Hold
1,161
0.06% 98
2021
Q1
$99K Hold
1,161
0.06% 101
2020
Q4
$110K Hold
1,161
0.07% 96
2020
Q3
$101K Hold
1,161
0.07% 95
2020
Q2
$101K Hold
1,161
0.08% 92
2020
Q1
$96K Hold
1,161
0.09% 83
2019
Q4
$110K Hold
1,161
0.08% 89
2019
Q3
$101K Sell
1,161
-253
-18% -$22.7K 0.08% 88
2019
Q2
$129K Buy
+1,414
New +$120K 0.1% 82

Other funds holding NVS

Truehand Inc's NVS Position: Q4 2021 in Review

Truehand Inc held its Novartis (NVS) position steady in Q4 2021 at 1,161 shares worth $102K. The position accounts for 0.06% of the portfolio, ranked #103.

Truehand Inc first reported a position in NVS in Q2 2019 and has held it in 11 quarters since. The position peaked at $129K in Q2 2019. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Truehand Inc held 1,161 shares of Novartis worth $102K as of Q4 2021.
  • Truehand Inc left its Novartis share count unchanged in Q4 2021.
  • Novartis made up 0.06% of Truehand Inc's portfolio in Q4 2021, its #103 holding.
  • Truehand Inc first reported a position in Novartis in Q2 2019 and has held it in 11 quarters since.
  • Truehand Inc's Novartis position peaked at $129K in Q2 2019.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.